HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma (Q34520094)

2 August 2017

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma (English)

1 reference

2 August 2017

Peir-In Liang

1

1 reference

2 August 2017

Wei-Ming Li

2

1 reference

2 August 2017

Yu-Hui Wang

3

1 reference

2 August 2017

Ting-Feng Wu

4

1 reference

2 August 2017

Wen-Ren Wu

5

1 reference

2 August 2017

Alex C Liao

6

1 reference

2 August 2017

Kun-Hung Shen

7

1 reference

2 August 2017

Yu-Ching Wei

8

1 reference

2 August 2017

Chung-Hsi Hsing

9

1 reference

2 August 2017

Yow-Ling Shiue

10

1 reference

2 August 2017

Hsuan-Ying Huang

11

1 reference

2 August 2017

Han-Ping Hsu

12

1 reference

2 August 2017

Li-Tzon Chen

13

1 reference

2 August 2017

Ching-Yih Lin

14

1 reference

2 August 2017

Chein Tai

15

1 reference

2 August 2017

Chun-Mao Lin

16

1 reference

2 August 2017

Chien-Feng Li

17

1 reference

2 August 2017

language of work or name

English

0 references

publication date

21 December 2012

1 reference

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

611

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-12-611

2 August 2017

0 references

cites work

Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

7 July 2018

HuR function in disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Posttranscriptional regulation of cancer traits by HuR

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Prognostic factors for upper urinary tract urothelial carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

HuR knockdown changes the oncogenic potential of oral cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Diverse molecular functions of Hu proteins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

RNA regulons: coordination of post-transcriptional events

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

From birth to death: the complex lives of eukaryotic mRNAs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Role of the RNA-binding protein HuR in colon carcinogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

E- and A-type cyclins as markers for cancer diagnosis and prognosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Cyclin A in cell cycle control and cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

The schedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3571926

Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-611

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-611

Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-611

Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-611

Behavior of Urothelial Carcinoma With Respect to Anatomical Location

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-611

Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection

21 January 2018

1 reference

12 December 2020

Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody

1 reference

12 December 2020

Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis

1 reference

12 December 2020

Prognostic significance of cyclin A in gastric cancer

1 reference

12 December 2020

Ureteral tumour: a specific upper urinary tract transitional cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-12-611

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference